DBV Technologies S.A. (DBVT) Financials

DBVT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 223.2 million 62.8 million
March 31, 2026 266.4 million 58.5 million
Dec. 31, 2025 233.7 million 64.9 million
Sept. 30, 2025 110.5 million 57.6 million

DBVT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -83.1 million 4.3 million
March 31, 2026 -49.5 million 2.3 million
Dec. 31, 2025 -35.6 million 1.9 million
Sept. 30, 2025 -32.6 million 516000

DBVT Net Income

No data available :(

DBVT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 174.9 million - 6.9 million
March 31, 2026 229.2 million - 5.1 million
Dec. 31, 2025 194.2 million - 5.4 million
Sept. 30, 2025 69.8 million - 6.7 million

DBVT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 85.7 million
March 31, 2026 85.7 million
Dec. 31, 2025 76.6 million
Sept. 30, 2025 96.2 million

DBVT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 10000 31.2 million 20.1 million 5.5 million
March 31, 2026 400000 33.4 million 13.4 million 4.8 million
Dec. 31, 2025 379000 32.9 million 11.3 million -
Sept. 30, 2025 117000 26.8 million 5.8 million -24858

DBVT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 4.2 million
Dec. 31, 2025 - 4.3 million
Sept. 30, 2025 - 4.3 million

DBVT

Price: $8.87

52 week price:
8.87
26.19

Earnings Per Share: -3.50 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 78800

Ebitda: -157.7 million

Market Capitalization: 252.4 million

Links: